Biotools Licenses Genetic Probes to Diapro | GenomeWeb
NEW YORK (GenomeWeb News) – Madrid, Spain-based Biotools B&M Labs has licensed its Lionprobes technology to Milan, Italy-based Diapro for detection of nucleic acids on real-time DNA amplification platforms using fluorescent-labeled probes with application in medical diagnostics and prognosis.
 
Diapro will use the Lionprobes technology to develop new kits that offer a fluorescent system for detecting, quantifying, and analyzing nucleic acid sequences, said Biotools.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.